Clinical trial
14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis
NCT03999528 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis
- Lead sponsor
- Al-Azhar University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- August 1, 2019
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoporosis, rheumatoid arthritis